PEAK PHARMACEUTICALS, INC.
CERTIFICATION PURSUANT TO 18 U.S.C.
SECTION 1350 AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF
In connection with this
Annual Report on Form 10-K of Peak Pharmaceuticals, Inc. (the “Company”) for the period ended September 30, 2017 as
filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, in the capacity
and on the date indicated below, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that to his knowledge:
||The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
||The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. |
||January 12, 2018
||/s/ Neil Reithinger
Chief Financial Officer
(Principal Financial Officer and Principal